Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
15 Febbraio 2024 - 3:13AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Avalo Therapeutics, Inc.
(Name of Issuer)
Common Stock, $0.001 par value per share
(Title of Class of
Securities)
05338F306
(CUSIP Number)
December 31, 2023
(Date of Event
Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:
¨ |
Rule 13d-1(b) |
|
|
x |
Rule 13d-1(c) |
|
|
¨ |
Rule 13d-1(d) |
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall
not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or
otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
CUSIP No. 05338F306 | Page 2 of 14 |
1. |
Names of Reporting Persons
Venrock Healthcare Capital Partners III, L.P. |
2. |
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) x (1) (b)
¨ |
3. |
SEC Use Only |
|
|
4. |
Citizenship or Place of Organization
Delaware |
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
5. |
Sole Voting Power
0 |
6. |
Shared Voting Power
0 |
7. |
Sole Dispositive Power
0 |
8. |
Shared Dispositive Power
0 |
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
0 |
10. |
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions) ¨ |
|
|
11. |
Percent of Class Represented by Amount in Row (9)
0.0% |
12. |
Type of Reporting Person (See Instructions)
PN |
|
|
|
|
(1) | Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings
III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG,
LLC, Nimish Shah and Bong Koh are members of a group for the purposes of this Schedule 13G/A. |
| |
CUSIP No. 05338F306 | Page 3 of 14 |
1. |
Names of Reporting Persons
VHCP Co-Investment Holdings III, LLC |
2. |
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) x (1) (b)
¨ |
3. |
SEC Use Only |
|
|
4. |
Citizenship or Place of Organization
Delaware |
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
5. |
Sole Voting Power
0 |
6. |
Shared Voting Power
0 |
7. |
Sole Dispositive Power
0 |
8. |
Shared Dispositive Power
0 |
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
0 |
10. |
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions) ¨ |
|
|
11. |
Percent of Class Represented by Amount in Row (9)
0.0% |
12. |
Type of Reporting Person (See Instructions)
OO |
|
|
|
|
| (1) | Venrock Healthcare Capital Partners III,
L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P.,
VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of
a group for the purposes of this Schedule 13G/A. |
CUSIP No. 05338F306 | Page 4 of 14 |
1. |
Names of Reporting Persons
Venrock Healthcare Capital Partners EG, L.P. |
2. |
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) x (1) (b)
¨ |
3. |
SEC
Use Only |
|
|
4. |
Citizenship or Place of Organization
Delaware |
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
5. |
Sole Voting Power
0 |
6. |
Shared Voting Power
0 |
7. |
Sole Dispositive Power
0 |
8. |
Shared Dispositive Power
0 |
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
0 |
10. |
Check if the Aggregate Amount in Row
(9) Excludes Certain Shares (See Instructions) ¨ |
|
|
11. |
Percent of Class Represented by Amount in Row (9)
0.0% |
12. |
Type of Reporting Person (See Instructions)
PN |
|
|
|
|
| (1) | Venrock Healthcare Capital Partners III,
L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P.,
VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of
a group for the purposes of this Schedule 13G/A. |
CUSIP No. 05338F306 | Page 5 of 14 |
1. |
Names of Reporting Persons
VHCP Management III, LLC |
2. |
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) x (1) (b)
¨ |
3. |
SEC
Use Only
|
4. |
Citizenship or Place of Organization
Delaware |
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
5. |
Sole Voting Power
0 |
6. |
Shared Voting Power
0 |
7. |
Sole Dispositive Power
0 |
8. |
Shared Dispositive Power
0 |
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
0 |
10. |
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐
|
11. |
Percent of Class Represented by Amount in Row (9)
0.0% |
12. |
Type of Reporting Person (See Instructions)
OO |
|
|
|
|
| (1) | Venrock Healthcare Capital Partners III,
L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P.,
VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of
a group for the purposes of this Schedule 13G/A. |
CUSIP No. 05338F306 | Page 6 of 14 |
1. |
Names of Reporting Persons
VHCP Management EG, LLC |
2. |
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) x (1) (b)
¨ |
3. |
SEC
Use Only
|
4. |
Citizenship or Place of Organization
Delaware |
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
5. |
Sole Voting Power
0 |
6. |
Shared Voting Power
0 |
7. |
Sole Dispositive Power
0 |
8. |
Shared Dispositive Power
0 |
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
0 |
10. |
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
|
11. |
Percent of Class Represented by Amount in Row (9)
0.0% |
12. |
Type of Reporting Person (See Instructions)
OO |
|
|
|
|
| (1) | Venrock Healthcare Capital Partners III,
L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P.,
VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of
a group for the purposes of this Schedule 13G/A. |
CUSIP No. 05338F306 | Page 7 of 14 |
1. |
Names of Reporting Persons
Shah, Nimish |
2. |
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ☒
(1) (b) ☐ |
3. |
SEC
Use Only
|
4. |
Citizenship or Place of Organization
United States |
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
5. |
Sole Voting Power
0 |
6. |
Shared Voting Power
0 |
7. |
Sole Dispositive Power
0 |
8. |
Shared Dispositive Power
0 |
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
0 |
10. |
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐
|
11. |
Percent of Class Represented by Amount in Row (9)
0.0% |
12. |
Type of Reporting Person (See Instructions)
IN |
|
|
|
|
| (1) | Venrock Healthcare Capital Partners III,
L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P.,
VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of
a group for the purposes of this Schedule 13G/A. |
CUSIP No. 05338F306 | Page 8 of 14 |
1. |
Names of Reporting Persons
Koh, Bong |
2. |
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) x (1) (b)
¨ |
3. |
SEC
Use Only
|
4. |
Citizenship or Place of Organization
United States |
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With |
5. |
Sole Voting Power
0 |
6. |
Shared Voting Power
0 |
7. |
Sole Dispositive Power
0 |
8. |
Shared Dispositive Power
0 |
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
0 |
10. |
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨
|
11. |
Percent of Class Represented by Amount in Row (9)
0.0% |
12. |
Type of Reporting Person (See Instructions)
IN |
|
|
|
|
| (1) | Venrock Healthcare Capital Partners III,
L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P.,
VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah and Bong Koh are members of
a group for the purposes of this Schedule 13G/A. |
CUSIP No. 05338F306 | Page 9 of 14 |
Introductory Note: This Schedule 13G/A
is filed on behalf of Venrock Healthcare Capital Partners III, L.P., a limited partnership organized under the laws of the State of Delaware
(“VHCP III LP”), VHCP Co-Investment Holdings III, LLC, a limited liability company organized under the laws of the State of
Delaware (“VHCP Co-Investment III”), Venrock Healthcare Capital Partners EG, L.P., a limited partnership organized under the
laws of the State of Delaware (“VHCP EG”), VHCP Management III, LLC, a limited liability company organized under the laws
of the State of Delaware (“VHCP Management III”), VHCP Management EG, LLC, a limited liability company organized under the
laws of the State of Delaware (“VHCP Management EG” and collectively with VHCP III LP, VHCP Co-Investment III, VHCP EG and
VHCP Management III, the “Venrock Entities”), Nimish Shah (“Shah”) and Bong Koh (“Koh”) in respect
of the Common Stock of Avalo Therapeutics, Inc.
Item 1. |
|
(a) |
Name of Issuer
Avalo Therapeutics, Inc. |
|
|
(b) |
Address of Issuer’s Principal Executive Offices
540 Gaither Road, Suite 400
Rockville, MD 20850 |
|
Item 2. |
|
(a) |
Name of Person Filing
Venrock Healthcare Capital Partners III, L.P.
VHCP Co-Investment Holdings III, LLC
Venrock Healthcare Capital Partners EG, L.P.
VHCP Management III, LLC
VHCP Management EG, LLC
Nimish Shah
Bong Koh |
|
|
(b) |
Address of Principal Business Office or, if none, Residence
|
|
|
New York Office: |
Palo Alto Office: |
|
|
|
|
|
7 Bryant Park |
3340 Hillview Avenue |
|
|
23rd Floor |
Palo Alto, CA 94304 |
|
|
New York, NY 10018 |
|
|
(c) |
Citizenship
All of the Venrock Entities were organized
in Delaware. The individuals are both United States citizens. |
|
|
(d) |
Title of Class of Securities
Common Stock, $0.001 par value |
|
|
(e) |
CUSIP Number
05338F306 |
|
|
|
|
CUSIP No. 05338F306 | Page 10 of 14 |
Item 3. |
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
|
|
|
Not applicable |
Item 4. |
Ownership |
|
|
|
(a) |
Amount beneficially owned as of February 14, 2024: |
Venrock Healthcare Capital Partners III, L.P. | |
| 0 |
|
VHCP Co-Investment Holdings III, LLC | |
| 0 |
|
Venrock Healthcare Capital Partners EG, L.P. | |
| 0 |
|
VHCP Management III, LLC | |
| 0 |
|
VHCP Management EG, LLC | |
| 0 |
|
Nimish Shah | |
| 0 |
|
Bong Koh | |
| 0 |
|
|
(b) |
Percent of class as of February 14, 2024: |
Venrock Healthcare Capital Partners III, L.P. | |
| 0.0 |
% |
VHCP Co-Investment Holdings III, LLC | |
| 0.0 |
% |
Venrock Healthcare Capital Partners EG, L.P. | |
| 0.0 |
% |
VHCP Management III, LLC | |
| 0.0 |
% |
VHCP Management EG, LLC | |
| 0.0 |
% |
Nimish Shah | |
| 0.0 |
% |
Bong Koh | |
| 0.0 |
% |
|
(c) |
Number of shares as to which the person
has, as of February 14, 2024: |
|
|
|
|
|
(i) |
Sole power to vote or to direct the vote: |
Venrock Healthcare Capital Partners III, L.P. | |
| 0 | |
VHCP Co-Investment Holdings III, LLC | |
| 0 | |
Venrock Healthcare Capital Partners EG, L.P. | |
| 0 | |
VHCP Management III, LLC | |
| 0 | |
VHCP Management EG, LLC | |
| 0 | |
Nimish Shah | |
| 0 | |
Bong Koh | |
| 0 | |
|
|
(ii) |
Shared power to vote or to direct the vote: |
Venrock Healthcare Capital Partners III, L.P. | |
| 0 |
|
VHCP Co-Investment Holdings III, LLC | |
| 0 |
|
Venrock Healthcare Capital Partners EG, L.P. | |
| 0 |
|
VHCP Management III, LLC | |
| 0 |
|
VHCP Management EG, LLC | |
| 0 |
|
Nimish Shah | |
| 0 |
|
Bong Koh | |
| 0 |
|
| |
| |
CUSIP No. 05338F306 | Page 11 of 14 |
|
(iii) |
Sole power to dispose or to direct the disposition
of: |
Venrock Healthcare Capital Partners III, L.P. | |
| 0 | |
VHCP Co-Investment Holdings III, LLC | |
| 0 | |
Venrock Healthcare Capital Partners EG, L.P. | |
| 0 | |
VHCP Management III, LLC | |
| 0 | |
VHCP Management EG, LLC | |
| 0 | |
Nimish Shah | |
| 0 | |
Bong Koh | |
| 0 | |
|
|
(iv) |
Shared power to dispose or to direct the disposition
of: |
Venrock Healthcare Capital Partners III, L.P. | |
| 0 |
|
VHCP Co-Investment Holdings III, LLC | |
| 0 |
|
Venrock Healthcare Capital Partners EG, L.P. | |
| 0 |
|
VHCP Management III, LLC | |
| 0 |
|
VHCP Management EG, LLC | |
| 0 |
|
Nimish Shah | |
| 0 |
|
Bong Koh | |
| 0 |
|
CUSIP No. 05338F306 | Page 12 of 14 |
Item 5. |
Ownership of Five Percent or
Less of a Class |
|
|
|
If this statement is being
filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following x |
|
Item 6. |
Ownership of More than Five Percent on Behalf of
Another Person |
|
|
|
Not applicable |
|
Item 7. |
Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person |
|
|
|
Not applicable |
|
Item 8. |
Identification and Classification of Members of
the Group |
|
|
|
Not applicable |
|
Item 9. |
Notice of Dissolution of Group |
|
|
|
Not applicable |
|
Item 10. |
Certification |
|
|
|
By signing below I certify
that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having such purpose or effect. |
CUSIP No. 05338F306 | Page 13 of 14 |
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 14, 2024
Venrock Healthcare Capital Partners
III, L.P. |
|
Venrock Healthcare Capital Partners
EG, L.P. |
|
|
|
|
|
By: |
VHCP Management III, LLC |
|
By: |
VHCP Management EG, LLC |
Its: |
General Partner |
|
Its: |
General Partner |
|
|
|
|
|
By: |
/s/ Sherman
G. Souther |
|
By: |
/s/ Sherman
G. Souther |
|
Name: Sherman G. Souther |
|
|
Name: Sherman G. Souther |
|
Its: Authorized Signatory |
|
|
Its: Authorized Signatory |
|
|
|
|
|
VHCP Co-Investment Holdings III, LLC |
|
|
|
|
|
|
|
|
By: |
VHCP Management III, LLC |
|
|
|
Its: |
Manager |
|
|
|
|
|
|
|
|
By: |
/s/ Sherman
G. Souther |
|
|
|
|
Name: Sherman G. Souther |
|
|
|
|
Its: Authorized Signatory |
|
|
|
|
|
|
|
|
VHCP Management III, LLC |
|
VHCP Management EG, LLC |
|
|
|
|
|
By: |
/s/ Sherman
G. Souther |
|
By: |
/s/ Sherman
G. Souther |
|
Name: Sherman G. Souther |
|
|
Name: Sherman G. Souther |
|
Its: Authorized Signatory |
|
|
Its: Authorized Signatory |
|
|
|
|
|
Nimish Shah |
|
|
|
|
|
|
|
/s/
Sherman G. Souther |
|
|
|
Sherman G. Souther, Attorney-in-fact |
|
|
|
|
|
|
|
|
Bong Koh |
|
|
|
|
|
|
|
/s/
Sherman G. Souther |
|
|
|
Sherman G. Souther, Attorney-in-fact |
|
|
|
CUSIP No. 05338F306 | Page 14 of 14 |
EXHIBITS
Grafico Azioni Avalo Therapeutics (NASDAQ:AVTX)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Avalo Therapeutics (NASDAQ:AVTX)
Storico
Da Dic 2023 a Dic 2024